Cargando…

Feasibility of canakinumab withdrawal in colchicine-resistant familial Mediterranean fever

OBJECTIVES: There is no consensus on canakinumab treatment tapering and discontinuation strategies in colchicine-resistant FMF patients. In this study, we aimed to establish a treatment management and discontinuation protocol in paediatric FMF patients treated with canakinumab. METHODS: Fifty-eight...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sener, Seher, Cam, Veysel, Batu, Ezgi Deniz, Kasap Cuceoglu, Muserref, Balik, Zeynep, Aliyev, Emil, Bayindir, Yagmur, Basaran, Ozge, Bilginer, Yelda, Ozen, Seza
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Clinical Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10629778/ https://www.ncbi.nlm.nih.gov/pubmed/36961326 http://dx.doi.org/10.1093/rheumatology/kead128

Ejemplares similares

Patients Without a Rheumatic Disease Diagnosis in a Pediatric Rheumatology Unit: Retrospective Analysis and Comparison Between Pre-pandemic and Pandemic Periods
por: Kaya Akca, Ümmüşen, et al.
Publicado: (2023)

Impact of the COVID-19 pandemic on the frequency of the pediatric rheumatic diseases
por: Kaya Akca, Ummusen, et al.
Publicado: (2021)

Two siblings with Majeed syndrome and neutropenia
por: Kasap Cuceoglu, Muserref, et al.
Publicado: (2022)

The Effect of Biologics in the Treatment of Multisystem Inflammatory Syndrome in Children (Mis-C): A Single-Center Propensity-Score-Matched Study †
por: Basaran, Ozge, et al.
Publicado: (2023)

Hypersensitivity to Biological Treatments in Juvenile Idiopathic Arthritis: How Should It Be Managed?
por: Kasap Cuceoglu, Muserref, et al.
Publicado: (2022)

Rare Autoinflammatory Diseases
por: Başaran, Özge, et al.
Publicado: (2022)

COVID-19 associated pediatric vasculitis: A systematic review and detailed analysis of the pathogenesis
por: Batu, Ezgi Deniz, et al.
Publicado: (2022)

Reply on: COVID-19 associated pediatric vasculitis: A systematic review and detailed analysis of the pathogenesis
por: Batu, Ezgi Deniz, et al.
Publicado: (2022)

The difference of the inflammatory milieu in MIS-C and severe COVID-19
por: Gurlevik, Sibel Lacinel, et al.
Publicado: (2022)

Renal amyloidosis in children
por: Bilginer, Yelda, et al.
Publicado: (2011)

OR7-005 – Canakinumab in childhood colchicine resistant FMF
por: Hashkes, PJ, et al.
Publicado: (2013)

Vasculitis Pathogenesis: Can We Talk About Precision Medicine?
por: Ozen, Seza, et al.
Publicado: (2018)

Implications of COVID-19 in pediatric rheumatology
por: Batu, Ezgi Deniz, et al.
Publicado: (2020)

Behçet’s disease in children: single-center experience
por: Çirkinoğlu, Murat Soner, et al.
Publicado: (2019)

Long-term efficacy and safety of canakinumab in patients with colchicine-resistant familial Mediterranean fever: results from the randomised phase III CLUSTER trial
por: Ozen, Seza, et al.
Publicado: (2020)

PW01-015 – Canakinumab in adults with colchicin resistant FMF
por: Gül, A, et al.
Publicado: (2013)

Familial Mediterranean Fever: Recent Developments in Pathogenesis and New Recommendations for Management
por: Özen, Seza, et al.
Publicado: (2017)

Kawasaki-like disease in children with COVID-19
por: Akca, Ummusen Kaya, et al.
Publicado: (2020)

Pleural effusion as an atypical presentation of Kawasaki disease: a case report and review of the literature
por: Arslanoglu Aydin, Elif, et al.
Publicado: (2019)

Quality of life changes with canakinumab therapy in adults with colchicine resistant FMF
por: Gul, A, et al.
Publicado: (2015)

Treatment of familial mediterranean fever with canakinumab in patients who are unresponsive to colchicine
por: Berdeli, Afig, et al.
Publicado: (2019)

Effectiveness of Canakinumab Treatment in Colchicine Resistant Familial Mediterranean Fever Cases
por: Yücel, Burcu Bozkaya, et al.
Publicado: (2021)

Anti-inflammatory therapy in ischaemic heart disease: from canakinumab to colchicine
por: Andreotti, Felicita, et al.
Publicado: (2021)

61 The nailfold videocapillaroscopy in pediatric Behçet’s disease: a multi-center study
por: Çakmak, Figen, et al.
Publicado: (2022)

Familial Mediterranean fever: current perspectives
por: Sönmez, Hafize Emine, et al.
Publicado: (2016)

Editorial: DADA2 and other monogenic vasculitides
por: Lee, Pui Y., et al.
Publicado: (2022)

Choroidal vascularity index as a biomarker of systemic inflammation in childhood Polyarteritis Nodosa and adenosine deaminase-2 deficiency
por: BAYTAROĞLU, Ata, et al.
Publicado: (2020)

Hematological features in children with systemic lupus erythematosus: are they more common than appreciated?
por: Gokce, Muge, et al.
Publicado: (2011)

The clinical course of SARS-CoV-2 infection among children with rheumatic disease under biologic therapy: a retrospective and multicenter study
por: Sozeri, Betul, et al.
Publicado: (2021)

Efficacy and safety of canakinumab in adolescents and adults with colchicine-resistant familial Mediterranean fever
por: Gül, Ahmet, et al.
Publicado: (2015)

A proposed treatment scheme for chronic recurrent multifocal osteomyelitis (CRMO): a case series of nine patients
por: Batu, Ezgi Deniz, et al.
Publicado: (2014)

PW01-002 – Colchicine resistant FMF in Turkish children
por: Eroglu, FK Kara, et al.
Publicado: (2013)

The role of clinical pilates exercises in children wıth juvenile idiopathic arthritis: a pilot study
por: Unal, Edibe, et al.
Publicado: (2011)

PW01-005 – Effects of placebo and colchicine on FMF patients
por: Özaltın, F, et al.
Publicado: (2013)

How the COVID-19 pandemic has influenced pediatric rheumatology practice: Results of a global, cross-sectional, online survey
por: Batu, Ezgi Deniz, et al.
Publicado: (2020)

Effectiveness of Colchicine or Canakinumab in Japanese Patients with Familial Mediterranean Fever: A Single-Center Study
por: Yoshida, Shuhei, et al.
Publicado: (2023)

PReS-FINAL-2218: Treatment of colchicines resistant FMF: experience of a pediatric center in Turkey
por: Kara Eroglu, F, et al.
Publicado: (2013)

Plasma Proteomic Analysis Reveals the Potential Role of Lectin and Alternative Complement Pathways in IgA Vasculitis Pathogenesis
por: Demir, Selcan, et al.
Publicado: (2023)

PW03-001 - PFAPA syndrome in Turkish children
por: Batu, ED, et al.
Publicado: (2013)

Development of focal segmental glomerulosclerosis in a patient with Familial Mediterranean Fever resistant to colchicine therapy under treatment with Canakinumab
por: Barut, K, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_3949ass66vdu4hlngd8qflk03i